Dexcel Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Dexcel Pharma's estimated annual revenue is currently $119.6M per year.
- Dexcel Pharma's estimated revenue per employee is $201,000
Employee Data
- Dexcel Pharma has 595 Employees.
- Dexcel Pharma grew their employee count by 4% last year.
Dexcel Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Chief Scientist, RNA Therapeutics | Reveal Email/Phone |
3 | Head Quality | Reveal Email/Phone |
4 | Pharmacovigilance Officer | Reveal Email/Phone |
5 | Head Finance Tax & Treasury | Reveal Email/Phone |
6 | VP & General Manager Dexcel Pharma Israel | Reveal Email/Phone |
7 | VP, General Counsel | Reveal Email/Phone |
8 | Head Quality Control | Reveal Email/Phone |
9 | VP Research and Development | Reveal Email/Phone |
10 | Head Laboratories | Reveal Email/Phone |
Dexcel Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Dexcel Pharma?
Dexcel Pharma is an international specialty pharmaceutical company which focuses on the development, manufacturing and marketing of innovative prescription, generics and OTC pharmaceutical products. Dexcel Pharma is Israel's largest private pharmaceutical company. Founded in 1968, we develop, manufacture and market value-added branded and generic pharmaceuticals. With a diverse product portfolio that spans more than 85 branded and generic products in over 175 dosage forms, our products are sold in the US, the UK and Germany, via subsidiaries and through a trusted network of partners in more than 30 countries worldwide.
keywords:N/A
N/A
Total Funding
595
Number of Employees
$119.6M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Dexcel Pharma News
Roivant Sciences Ltd. (NASDAQ:ROIV) Major Shareholder Pharma ... Defense World
Diclofenac Sodium Market Strategic Insights of Developing Industry ... The New York Irish Emgirant
Superdisintegrants Market to exceed USD 659.17 million by 2027 ... Digital Journal